We are live on ! Find out more
NERM

New England Research & Management Portfolio holdings

AUM $257M
1-Year Est. Return 25.66%
This Fund
S&P 500
This Quarter Est. Return
-0.01%
1 Year Est. Return
+25.66%
3 Year Est. Return
+56.38%
5 Year Est. Return
+58.71%
10 Year Est. Return
+176.32%
AUM
$170M
AUM Growth
-$3.54M
Cap. Flow
-$1.18M
Cap. Flow %
-0.69%
Top 10 Hldgs %
23.13%
Holding
180
New
28
Increased
33
Reduced
64
Closed
37

Top Buys

Rank Stock Value
1
SCHW
Charles Schwab
SCHW
+$2.22M
2
LYB icon
LyondellBasell Industries
LYB
+$1.49M
3
CB icon
Chubb
CB
+$1.46M
4
DLTR icon
Dollar Tree
DLTR
+$1.45M
5
AMGN icon
Amgen
AMGN
+$1.17M

Top Sells

Rank Stock Value
1
PB icon
Prosperity Bancshares
PB
+$2.95M
2
ON icon
ON Semiconductor
ON
+$1.24M
3
MRK icon
Merck
MRK
+$1.23M
4
FISV
Fiserv Inc
FISV
+$1.22M
5
AXP icon
American Express
AXP
+$1.09M

Sector Composition

Rank Sector Weight
1 Industrials 22.11%
2 Healthcare 19.78%
3 Consumer Staples 14.05%
4 Financials 9.51%
5 Technology 9.2%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
WY icon
176
Weyerhaeuser
WY
$16.1B
-10,240
Closed -$317K
ABB
177
DELISTED
ABB Ltd
ABB
-7,250
Closed -$221K

Similar funds

New England Research & Management's Q1 2023 Portfolio in Review

As of Q1 2023, New England Research & Management held 180 positions worth $170M, down 2% from $174M the previous quarter. Its ten largest holdings account for 23% of the portfolio.

New England Research & Management's Q1 2023 filing shows 28 new, 33 increased, 64 reduced and 37 closed positions. Its largest new stake was Charles Schwab: 30,305 shares worth $1.59M. The largest sale was Prosperity Bancshares, an estimated $2.95M.

By sector, the portfolio is most concentrated in Industrials at 22% of assets, up from 22% a quarter earlier, followed by Healthcare and Consumer Staples.

  • New England Research & Management's largest Q1 2023 buy was Charles Schwab: 30,305 shares worth $1.59M.
  • New England Research & Management added most to Amgen in Q1 2023, an estimated $1.17M increase.
  • New England Research & Management's biggest Q1 2023 reduction was Merck, cutting an estimated $1.23M.
  • New England Research & Management fully exited Prosperity Bancshares in Q1 2023, selling an estimated $2.95M.
  • New England Research & Management's ten largest holdings make up 23% of its $170M portfolio in Q1 2023.
  • New England Research & Management opened 28 new positions and closed 37 in Q1 2023.
  • New England Research & Management's portfolio value fell 2% quarter-over-quarter to $170M.

Based on New England Research & Management's 13F filing for Q1 2023, filed 6 Apr 2023.